President Donald Trump is correct that prescription drugs cost too much. Families are struggling, and no one should have to choose between paying for their child’s inhaler or rent. But a new partnership between Trump and Pfizer to sell drugs directly to consumers won’t cure the disease, but rather embrace the government favoritism that made healthcare unaffordable in the first place.

Washington, D.C., keeps trying to fix healthcare by controlling it, and that’s the real problem. Each new regulation, tariff, or political deal promises to make medicine more affordable, yet costs keep rising while innovation slows. The cure for high drug prices isn’t more government control. It’s competition, the one thing Washington, D.C., can’t seem to stop meddling with.

Recommended Stories

Shield

See Full Page